Skip to content

Medical emergency? What to do

Surgery can lower cancer risk in high-risk brca1/2 carriers

3-RXPublished January 14, 20092 min read

Key points

  • Prior research has shown that this procedure can help prevent breast, ovarian, and fallopian tube malignancies in these high-risk patients, but the magnitude of the risk reduction was unclear, lead author Dr.
  • The investigators report their findings in the Journal of the National Cancer Institute for January 21, 2009.
  • Despite the efficacy of this surgery in BRCA1/2 mutation carriers, the authors note that a residual cancer risk still remains.
  • SOURCE: Journal of the National Cancer Institute, January 21, 2009.

Removal of the ovaries and fallopian tubes, a surgical procedure referred to as salpingo-oophorectomy, in women who carry the BRCA1 or BRCA2 gene mutation, can lower their risk of breast cancer by about 50 percent and their risk of ovarian or fallopian tube cancer by roughly 80 percent, suggest the results of a review of 10 published studies.

Prior research has shown that this procedure can help prevent breast, ovarian, and fallopian tube malignancies in these high-risk patients, but the magnitude of the risk reduction was unclear, lead author Dr. Timothy R. Rebbeck, from the University of Pennsylvania School of Medicine and colleagues explain.

To investigate, the research team searched PubMed, a large medical database, for studies that examined breast or gynecologic cancer outcomes in BRCA mutation carriers who underwent salpingo-oophorectomy. Data from 10 studies were included in the review, also referred to as a meta-analysis.

The investigators report their findings in the Journal of the National Cancer Institute for January 21, 2009.

Salpingo-oophorectomy reduced the risk of breast cancer in BRCA1 and BRCA2 mutation carriers by 53 percent, the report indicates. Likewise, the operation was associated with a 79 percent reduced risk of BRCA1/2-related ovarian or fallopian tube cancer.

Despite the efficacy of this surgery in BRCA1/2 mutation carriers, the authors note that a residual cancer risk still remains. As such, other cancer risk reduction and screening approaches are still needed to fully reduce cancer rates and mortality in these high-risk patients.

In an accompanying editorial, Dr. Mark H. Greene and Dr. Phuong L. Mai, from the National Cancer Institute in Rockville, Maryland, comment that Dr. Rebbeck's team has "provided us with a meticulously executed, up-to-date meta-analysis that quantifies the reductions in the risks of breast and ovarian/fallopian tube cancer that follow salpingo-oophorectomy in BRCA1/2 mutation carriers."

SOURCE: Journal of the National Cancer Institute, January 21, 2009.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Keep reading

Brain

Italy court ruling links mobile phone use to tumor

Italy's supreme court has upheld a ruling that said there was a link between a business executive's brain tumor and his heavy mobile phone usage, potentially opening the door to further legal claims. The court's…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.